Pharmaceutical and Life Sciences Deals Insights Quarterly

November 2014
  • Print-friendly version
Pharmaceutical and Life Sciences Deals Insights Quarterly

At a glance

Q3 showcased strong M&A activity; particularly in the pharmaceutical industry. As companies complete deals, integration becomes a critical element of realizing deal synergies. In this publication we highlight some of the methods used to capture and maintain value from synergy opportunities in an acquisition. Additionally this quarter's report's market spotlight looks at how Mexico has established itself as an attractive environment for investment among pharmaceuticals and life sciences companies.

Further reading:

US Pharmaceuticals and Life Sciences Deals Insights Quarterly Q2 2014

US Pharmaceuticals and Life Sciences Deals Insights Quarterly Q1 2014

US Pharmaceuticals and Life Sciences Deals Insights Quarterly Q4 2013

US Pharmaceuticals and Life Sciences Deals Insights Quarterly Q3 2013

US Pharmaceuticals and Life Sciences Deals Insights Quarterly Q2 2013